Defining the pharmacologically intractable headache for clinical trials and clinical practice

Headache

Volumn 50, Issue 9, 2010, Pages 1499-1506

  Silberstein, Stephen D ^a   Dodick, David W ^b   Pearlman, Starr ^c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b MAYO CLINIC   (United States)

^c Armstrong Atlantic State University   (United States)

Author keywords

clinical trial; intractable headache; migraine; refractory headache

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; FLUNARIZINE; GABAPENTIN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIPTAN DERIVATIVE; VALPROIC ACID; VERAPAMIL;

CLINICAL PRACTICE; DISABILITY; DISEASE SEVERITY; HEADACHE; HEADACHE RELATED DISABILITY; HUMAN; INTRACTABLE HEADACHE; MEDICAL RESEARCH; PRIORITY JOURNAL; REVIEW; TREATMENT FAILURE;

ANALGESICS; CLINICAL TRIALS AS TOPIC; DRUG RESISTANCE; HEADACHE DISORDERS; HUMANS; PAIN, INTRACTABLE; PRACTICE GUIDELINES AS TOPIC; TREATMENT FAILURE;

EID: 77957738937     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2010.01764.x     Document Type: Review

References (20)

1. Oxford English Dictionary. Intractable. Available at: http://dictionary.oed.com/cgi/entry/50120018?single=1&query-type= word&queryword=intractable&first=1&max-to-show=10 (last accessed 30 August 2010).
2. Dowson A, Mullen MJ, Peatfield R, et al. Migraine Intervention With STARFlex Technology (MIST) trial: A prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation. 2008 117 : 1397 1404.
3. Bigal M, Rapoport A, Sheftell F, Tepper D, Tepper S. Memantine in the preventive treatment of refractory migraine. Headache. 2008 48 : 1337 1342.
4. Goadsby PJ, Dodick D, Mitsias P, et al. ONSTIM: Occipital nerve stimulation for the treatment of chronic migraine. Eur J Neurol. 2005 12 (Suppl. 2 198.
5. Franzini A, Ferroli P, Leone M, Broggi G. Stimulation of the posterior hypothalamus for treatment of chronic intractable cluster headaches. The first reported series. Neurosurgery. 2003 52 : 1095 1101.
6. The International Classification of Headache Disorders: 2nd edition. Headache Classification Subcommittee of the International Headache Society. Cephalalgia. 2004 24 (Suppl 1 9 160.
7. Lipton RB, Stewart WF, Stone AM, Láinez MJ, Sawyer JP, Disability in Strategies of Care Study group. Stratified care vs step care strategies for migraine: The Disability in Strategies of Care (DISC) Study: A randomized trial. JAMA. 2000 284 : 2599 2605.
8. Lipton RB, Stewart WF, Sawyer J, Edmeads JG. Clinical utility of an instrument assessing migraine disability: The migraine disability assessment (MIDAS) questionnaire. Headache. 2001 41 : 854 861.
9. Pryse-Phillips W. Evaluating migraine disability: The headache impact test instrument in context. Can J Neurol Sci. 2002 29 (Suppl 2 S11 S15.
10. Schulman EA, Lake AE, Goadsby PJ, et al. Defining refractory migraine and refractory chronic migraine: Proposed criteria from the refractory headache special interest section of the American Headache Society. Headache. 2008 48 : 778 782.
11. Lipton RB, Silberstein SD, Saper JR, Bigal ME, Goadsby PJ. Why headache treatments fail. Neurology. 2003 60 : 1064 1070.
12. Classification Committee, Olesen J, Bousser MG, Diener HC, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006 26 : 742 746.
13. D'Amico D, Leone M, Grazzi L, Bussone G. When should "chronic migraine" patients be considered "refractory" to pharmacological to pharmacological prophylaxis? Neurol Sci. 2008 29 : S55 S58.
14. Goadsby PJ, Schoenen J, Ferrari M, et al. Towards a definition of refractory headache for use in clinical practice and trials. Cephalalgia. 2006 26 : 1168 1170.
15. Kwan P, Brodie M. Early identification of refractory epilepsy. N Engl J Med. 2000 342 : 314 319.
16. French JA. Refractory epilepsy: One size does not fit all. Epilepsy Curr. 2006 6 : 177 180.
17. Dodick DW. Reflections and speculations on refractory migraine: Why do some patients fail to improve with currently available therapies? Headache. 2008 48 : 828 837.
18. Olesen J, Goadsby PJ. Cluster headaches and related conditions. In : Olesen J, ed. Frontiers in Headache Research, Vol 9. Oxford, NY : Oxford University Press 1999.
19. Diener HC, Bussone G, Van Oene JC, et al. Topiramate reduces headache days in chronic migraine: A randomized, double-blind, placebo-controlled study. Cephalalgia. 2007 27 : 814 823.
20. Silberstein S, Lipton RB, Dodick DW, et al. Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double-blind, placebo-controlled trial. Headache. 2007 47 : 1 11.